Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 50% on Thursday . The company traded as high as C$0.11 and last traded at C$0.11. 1,942,446 shares changed hands during trading, an increase of 1,795% from the average session volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Price Performance
The stock has a market cap of C$14.64 million, a P/E ratio of -10.50 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm has a 50-day moving average price of C$0.07 and a 200-day moving average price of C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- P/E Ratio Calculation: How to Assess Stocks
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
